0.2428
price down icon3.34%   -0.0084
after-market Handel nachbörslich: .23 -0.0128 -5.27%
loading
Schlusskurs vom Vortag:
$0.2512
Offen:
$0.2546
24-Stunden-Volumen:
3.73M
Relative Volume:
0.22
Marktkapitalisierung:
$2.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.53M
KGV:
-0.0504
EPS:
-4.82
Netto-Cashflow:
$-11.12M
1W Leistung:
+13.99%
1M Leistung:
-7.58%
6M Leistung:
-64.40%
1J Leistung:
-85.38%
1-Tages-Spanne:
Value
$0.238
$0.2546
1-Wochen-Bereich:
Value
$0.2071
$0.2689
52-Wochen-Spanne:
Value
$0.15
$3.10

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name
Firmenname
Processa Pharmaceuticals Inc
Name
Telefon
443-776-3133
Name
Adresse
7380 COCA COLA DRIVE, HANOVER
Name
Mitarbeiter
13
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
PCSA's Discussions on Twitter

Vergleichen Sie PCSA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PCSA
Processa Pharmaceuticals Inc
0.2428 6.58M 0 -11.53M -11.12M -4.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-25 Eingeleitet H.C. Wainwright Buy

Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten

pulisher
Jul 25, 2025

What analysts say about Processa Pharmaceuticals Inc. stockFree Stock Market Query - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Processa Pharmaceuticals Files Prospectus for Stock Sale - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

NTLA CFO Sells 7,462 Shares in Tax Withholding Transaction – Form 4 | PCSA SEC FilingForm 424B5 - Stock Titan

Jul 25, 2025
pulisher
Jul 25, 2025

Processa Pharmaceuticals Inc. Stock Analysis and ForecastExponential wealth increase - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Processa Pharmaceuticals Inc. stock priceAccelerated profit realization - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

When is the best time to buy Processa Pharmaceuticals Inc. stockUnprecedented profit potential - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Is Processa Pharmaceuticals Inc. a good long term investmentConsistent triple-digit returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Processa Pharmaceuticals Inc (PCSA) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Processa Pharmaceuticals Inc. stock price move sharplyFree Wealth-Building Investment Strategies - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

Processa Pharmaceuticals Approves Key Proposals at Annual Meeting - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

RedChip Showcases Processa Pharmaceuticals and BullFrog AI on Bloomberg TV - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Foster's Daily Democrat

Jul 18, 2025
pulisher
Jul 18, 2025

The Convergence of AI and Biotech: BullFrog AI and Processa Pharmaceuticals as Catalysts for Disruption - AInvest

Jul 18, 2025
pulisher
Jul 16, 2025

How Processa Pharmaceuticals Inc. stock performs during market volatilityTrend Following Trades - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Processa Pharmaceuticals Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals Reschedules Annual Shareholder Meeting - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals to reconvene annual meeting after achieving quorum By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals to reconvene annual meeting after achieving quorum - Investing.com

Jul 15, 2025
pulisher
Jul 13, 2025

Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN

Jul 13, 2025
pulisher
Jul 11, 2025

Processa Pharmaceuticals: Betting on Catalyst-Driven Value Acceleration - AInvest

Jul 11, 2025

Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):